Loading...
Contact Us

BR-ORa

BioCellgraft > BR-ORa
Close
OraFyl Modal
×

Dr. Bachar Husseini, DDS, MSc – Key Contributions with OraFyl

  1. Pioneering Clinical Trials: Led first clinical split-mouth pilot study using OraFyl with allograft bone substitutes.
  2. Study Design: Conducted bilateral extraction studies with strict data collection protocols over 4 months.
  3. Major Findings:
    • Reduced bone resorption significantly.
    • Improved soft tissue healing and preservation.
    • Faster, healthier connective tissue formation.
  4. Scientific Innovation: Demonstrated effectiveness of flowable placental matrix without external growth factors.
  5. Broader Clinical Applications: Includes gingival recession, implants, bone graft bioactivation, cleft palate, and osteonecrosis.
  6. Leadership and Education: Establishing OraFyl as minimally invasive regenerative dental solution.
Close
OraFyl Modal
×

Dr. Bachar Husseini, DDS, MSc – Key Contributions with OraFyl

  1. Pioneering Clinical Trials: Led first clinical split-mouth pilot study using OraFyl with allograft bone substitutes.
  2. Study Design: Conducted bilateral extraction studies with strict data collection protocols over 4 months.
  3. Major Findings:
    • Reduced bone resorption significantly.
    • Improved soft tissue healing and preservation.
    • Faster, healthier connective tissue formation.
  4. Scientific Innovation: Demonstrated effectiveness of flowable placental matrix without external growth factors.
  5. Broader Clinical Applications: Includes gingival recession, implants, bone graft bioactivation, cleft palate, and osteonecrosis.
  6. Leadership and Education: Establishing OraFyl as minimally invasive regenerative dental solution.
© 2025 Biocellgraft All rights reserved.
Close
OraFyl Modal
×

Dr. Bachar Husseini, DDS, MSc – Key Contributions with OraFyl

  1. Pioneering Clinical Trials: Led first clinical split-mouth pilot study using OraFyl with allograft bone substitutes.
  2. Study Design: Conducted bilateral extraction studies with strict data collection protocols over 4 months.
  3. Major Findings:
    • Reduced bone resorption significantly.
    • Improved soft tissue healing and preservation.
    • Faster, healthier connective tissue formation.
  4. Scientific Innovation: Demonstrated effectiveness of flowable placental matrix without external growth factors.
  5. Broader Clinical Applications: Includes gingival recession, implants, bone graft bioactivation, cleft palate, and osteonecrosis.
  6. Leadership and Education: Establishing OraFyl as minimally invasive regenerative dental solution.